Log in to save to my catalogue

Metronomic chemotherapy patients: results of the VICTOR-6 study

Metronomic chemotherapy patients: results of the VICTOR-6 study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A680902148

Metronomic chemotherapy patients: results of the VICTOR-6 study

About this item

Full title

Metronomic chemotherapy patients: results of the VICTOR-6 study

Publisher

Springer

Journal title

Breast cancer research and treatment, 2021-12, Vol.190 (3), p.415

Language

English

Formats

Publication information

Publisher

Springer

More information

Scope and Contents

Contents

Purpose Triple-negative breast cancer (TNBC) represents a subtype of breast cancer which lacks the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2): TNBC accounts for approximately 20% of newly diagnosed breast cancers and is associated with younger age at diagnosis, greater recur...

Alternative Titles

Full title

Metronomic chemotherapy patients: results of the VICTOR-6 study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A680902148

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A680902148

Other Identifiers

ISSN

0167-6806

DOI

10.1007/s10549-021-06375-5

How to access this item